Market Place
Sourcing Support
Genetic test maker Invitae prepares for bankruptcy - WSJ
05 Feb 2024 //
REUTERS
Invitae Partners with BridgeBio Pharma to Harness Genetic Insights
30 Jan 2024 //
PR NEWSWIRE
Study Reveals Magnitude of Results in Genetic Testing for Hereditary Disease
25 Oct 2023 //
PR NEWSWIRE
Invitae announces partnership for realworld data sharing to rare cancer research
28 Oct 2022 //
PHARMABIZ
Invitae’s Real-World Ciitizen Data Utilized in Praxis Precision ’ PRAX-222 IND
20 Sep 2022 //
GLOBENEWSWIRE
Invitae`s Data Utilized in Praxis Precision Medicines` PRAX-222 IND Filing
20 Sep 2022 //
PRNEWSWIRE
Invitae collaborates with Simons Searchlight to accelerate research data
12 Sep 2022 //
PHARMABIZ
Why Invitae Stock Is Crashing Today
11 Aug 2022 //
FOOL
Invitae Reports $136.6 Million in Revenue in Second Quarter of 2022
09 Aug 2022 //
PRESS RELEASE
New NCCN CC Guidelines Recommend Genetic Testing for All Diagnosed Patients
08 Aug 2022 //
PRESS RELEASE
Invitae to Announce Q2 2022 Financial Results on Tuesday, August 9, 2022
02 Aug 2022 //
PRESS RELEASE
Invitae to Lay Off More Than 1K in Massive Restructuring Plan
21 Jul 2022 //
MDDIONLINE
Worldwide Clinical Trials Enters Into a Strategic Collaboration With Invitae
12 Jul 2022 //
BUSINESSWIRE
Invitae Launches Expanded Pharmacogenomics Panel and Mental Health Panel
19 May 2022 //
PRNEWSWIRE
American Society of Pharmacovigilance to Co-Host Virtual Congressional
22 Mar 2022 //
PRNEWSWIRE
Invitae launches first CE-IVD cancer testing kits in Europe
16 Feb 2022 //
PHARMAFILE
Invitae, UCL and FCI Announce New Data From TRACERx Research Collaboration
22 Oct 2021 //
BIOSPACE
Invitae to Acquire Consumer Health Tech Firm Ciitizen for $325M
08 Sep 2021 //
GENOMEWEB
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.